109 studies found for:    "Dilated cardiomyopathy"
Show Display Options
Rank Status Study
21 Unknown  A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Drug: Ranolazine
22 Enrolling by invitation Myocardial Metabolism in Patients With Dilated Cardiomyopathy
Conditions: Dilated Cardiomyopathy;   Type 2 Diabetes
Intervention:
23 Active, not recruiting Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)
Conditions: Dilated Cardiomyopathy (DCM);   Ischemic Cardiomyopathy;   Nonischemic Cardiomyopathy;   Heart Failure
Intervention: Biological: Allogeneic Cardiosphere-Derived Cells (CDCs)
24 Not yet recruiting Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy
Conditions: Heart Failure;   Dilated Cardiomyopathy
Intervention: Drug: Enalapril Orodispersible Minitablet
25 Completed Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells for Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: intramyocardial bone marrow stem cells implantation
26 Unknown  Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy
Conditions: Dilated Cardiomyopathy;   Heart Failure
Interventions: Drug: Qiliqiangxin capsule;   Drug: Placebo
27 Recruiting Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy
Condition: Primary Idiopathic Dilated Cardiomyopathy
Interventions: Other: bone marrow-derived MSCs injection;   Other: placebo intervention
28 Recruiting Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.
Condition: Idiopathic Dilated Cardiomyopathy
Interventions: Drug: Infusion of autologous mononuclear bone marrow cells;   Drug: Placebo infusion
29 Terminated NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated Cardiomyopathy
Condition: Chronic Systolic Heart Failure (Dilated Cardiomyopathy)
Intervention:
30 Active, not recruiting Danish ICD Study in Patients With Dilated Cardiomyopathy
Conditions: Heart Failure;   Dilated Cardiomyopathy;   Reduced LVEF
Interventions: Device: ICD;   Other: Optimal medical treatment
31 Completed Training Study to Evaluate the Benefit of Exercise for Patients With Chronic Heart Failure
Conditions: Dilated Cardiomyopathy;   Chronic Heart Failure
Intervention: Behavioral: Endurance training
32 Completed Resynchronization Therapy in Young Patients With and Without CHD
Conditions: Dilated Cardiomyopathy;   Pediatric
Intervention: Other: congestive heart failure patients
33 Completed The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle
Condition: Dilated Cardiomyopathy
Intervention: Drug: Tulip
34 Completed
Has Results
PUFAs and Left Ventricular Function in Heart Failure
Conditions: Dilated Cardiomyopathy;   Heart Failure
Interventions: Drug: n-3 PUFAs;   Drug: Placebo
35 Recruiting 18F-deoxyglucose (FDG) PET-CMD
Condition: Patients With Idiopathic Dilated Cardiomyopathy
Intervention: Drug: 18F-deoxyglucose (FDG)
36 Unknown  The Genetics of Dilated Cardiomyopathy: A Quebec-Based Study
Condition: Dilated Cardiomyopathy (DCM)
Intervention: Other: blood test
37 Unknown  Electrophysiologic and Morphologic Assessment of the Substrate to Guide Implantation of Defibrillators in Dilated Cardiomyopathy
Conditions: Dilated Cardiomyopathy;   Primary Prevention of Sudden Cardiac Death;   Implantable Cardioverter Defibrillator
Intervention:
38 Not yet recruiting Potential Role of Water-soluble Ubiquinol in Complementary Therapy for Pediatric Dilated Cardiomyopathy
Condition: Pediatric Dilated Cardiomyopathy
Intervention: Dietary Supplement: Water-soluble Ubiquinol
39 Completed A Trial of Autologous Bone Marrow Derived Stem Cells in Paediatric Heart Failure
Condition: Dilated Cardiomyopathy
Intervention: Biological: stem cell injection
40 Completed A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Condition: LMNA-Related Dilated Cardiomyopathy
Intervention: Drug: ARRY-371797, p38 inhibitor; oral

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years